16
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Smoking and E-Cigarette Use Among U.S. Adults During the COVID-19 Pandemic

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          With concerns about tobacco use being a risk factor for severe disease from coronavirus disease 2019 (COVID-19), understanding nicotine and tobacco use patterns is important for preventive efforts. This study aims to understand changes in combustible cigarette and e-cigarette use among U.S. adults.

          Methods

          In August 2020, a cross-sectional survey of a nationally representative sample of adults aged ≥18 years in the National Opinion Research Center's AmeriSpeak Panel who reported past 6–month use of combustible cigarettes or e-cigarettes was conducted. Multivariable logistic regression assessed factors associated with increased product use and quit attempts since hearing about COVID-19.

          Results

          A total of 1,024 past 6–month cigarette smokers/e-cigarette users were surveyed. Among cigarette smokers, 45% reported no change in cigarette smoking and 33% increased cigarette smoking since hearing about COVID-19. Higher stress was associated with increased cigarette smoking. Among e-cigarette users, 41% reported no change in and 23% reported increasing e-cigarette use. Twenty-six percent of cigarette smokers and 41% of e-cigarette users tried to quit because of COVID-19. Higher perceived risk of COVID-19 was associated with attempts to quit combustible cigarettes (AOR=2.37, 95% CI=1.59, 3.55) and e-cigarettes (AOR=3.14, 95% CI=1.73, 5.70).

          Conclusions

          Cigarette and e-cigarette use patterns varied in response to the COVID-19 pandemic. Most cigarette smokers and e-cigarette users perceived product use as increasing COVID-19-related health risks, and this was associated with attempts to quit. Some cigarette smokers, especially those reporting higher stress, increased product use. Proactive provision of cessation support to smokers and e-cigarette users may help mitigate stress-related increases in product use during the COVID-19 pandemic.

          Related collections

          Author and article information

          Journal
          Am J Prev Med
          Am J Prev Med
          American Journal of Preventive Medicine
          Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.
          0749-3797
          1873-2607
          6 October 2021
          6 October 2021
          Affiliations
          [1 ]Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
          [2 ]Tobacco Research and Treatment Center, The Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts
          [3 ]Harvard Medical School, Boston, Massachusetts
          Author notes
          [* ]Address correspondence to: Nancy Rigotti, MD, Division of General Internal Medicine, Massachusetts General Hospital, 100 Cambridge Street, Suite 1600, Boston MA 02114.
          Article
          S0749-3797(21)00499-2
          10.1016/j.amepre.2021.08.018
          8492610
          34756629
          feaa2570-de34-46cb-8c3f-435e2f43cac7
          © 2021 Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          Categories
          Article

          Medicine
          Medicine

          Comments

          Comment on this article